Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study

Abstract

Background:Black ethnic groups have a higher breast cancer mortality than Whites. American studies have identified variations in tumour biology and unequal health-care access as causative factors. We compared tumour pathology, treatment and outcomes in three ethnic groups in young breast cancer patients treated in the United Kingdom.Methods:Women aged ⩽40 years at breast cancer diagnosis were recruited to the POSH national cohort study (MREC: 00/06/69). Personal characteristics, tumour pathology and treatment data were collected at diagnosis. Follow-up data were collected annually. Overall survival (OS) and distant relapse-free survival (DRFS) were assessed using Kaplan–Meier curves, and multivariate analyses were performed using Cox regression.Results:Ethnicity data were available for 2915 patients including 2690 (91.0%) Whites, 118 (4.0%) Blacks and 87 (2.9%) Asians. Median tumour diameter at presentation was greater in Blacks than Whites (26.0 mm vs 22.0 mm, P=0.0103), and multifocal tumours were more frequent in both Blacks (43.4%) and Asians (37.0%) than Whites (28.9%). ER/PR/HER2-negative tumours were significantly more frequent in Blacks (26.1%) than Whites (18.6%, P=0.043). Use of chemotherapy was similarly high in all ethnic groups (89% B vs 88.6% W vs 89.7% A). A 5-year DRFS was significantly lower in Blacks than Asians (62.8% B vs 77.0% A, P=0.0473) or Whites (62.8 B% vs 77.0% W, P=0.0053) and a 5-year OS for Black patients, 71.1% (95% CI: 61.0–79.1%), was significantly lower than that of Whites (82.4%, 95% CI: 80.8–83.9%, W vs B: P=0.0160). In multivariate analysis, Black ethnicity had an effect on DRFS in oestrogen receptor (ER)-positive patients that is independent of body mass index, tumour size, grade or nodal status, HR: 1.60 (95% CI: 1.03–2.47, P=0.035).Conclusion:Despite equal access to health care, young Black women in the United Kingdom have a significantly poorer outcome than White patients. Black ethnicity is an independent risk factor for reduced DRFS particularly in ER-positive patients.

Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35)

“…In our study 12% of the patients had metastatic disease at the time of diagnosis. This is higher than it is reported in the POSH study (2.5%) where women aged ≤40 years were recruited (Copson et al, 2014).Our finding is similar with another study from Turkey; Uyetürk et al reported that 12.6% of breast cancer patients were presented with stage IV disease. There was no difference between stage IV and other stages in terms of age at diagnosis (Uyeturk et al, 2013).…”

Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities

“…There is limited, predominantly epidemiological, data on ethnic breast cancer within the UK population that points to similar variation in the biology and outcome of the disease across different backgrounds [21, 22]. …”

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry

“…11 In the UK, 5-year distant breast cancer relapse-free survival is 62·8% for young black women, compared with 77% for young white women with equal access to health care (p=0·0053). 12 Racial disparities in breast cancer survival between and within countries are linked to the availability of early detection, access to diagnosis and treatment, cultural differences in lifestyle behaviours, socioeconomic factors, and differences in the biological characteristics of breast cancer. 13 …”